EGV1.1 SELF MONITORING BLOOD GLUCOSE SYSTEM AND EGV1.1 PRO MONITORING BLOOD GLUCOSE SYSTEM

Glucose Dehydrogenase, Glucose

EPS BIO TECHNOLOGY CORP.

The following data is part of a premarket notification filed by Eps Bio Technology Corp. with the FDA for Egv1.1 Self Monitoring Blood Glucose System And Egv1.1 Pro Monitoring Blood Glucose System.

Pre-market Notification Details

Device IDK133537
510k NumberK133537
Device Name:EGV1.1 SELF MONITORING BLOOD GLUCOSE SYSTEM AND EGV1.1 PRO MONITORING BLOOD GLUCOSE SYSTEM
ClassificationGlucose Dehydrogenase, Glucose
Applicant EPS BIO TECHNOLOGY CORP. NO.8 R&D RD III HSINCHU SCIENCE PARK Hsinchu City,,  TW 30077
ContactCynthia Hung
CorrespondentCynthia Hung
EPS BIO TECHNOLOGY CORP. NO.8 R&D RD III HSINCHU SCIENCE PARK Hsinchu City,,  TW 30077
Product CodeLFR  
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2013-11-18
Decision Date2014-04-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.